CN102526610A - Traditional Chinese medicine for curing multiple takayasu arteritis - Google Patents
Traditional Chinese medicine for curing multiple takayasu arteritis Download PDFInfo
- Publication number
- CN102526610A CN102526610A CN2011104514072A CN201110451407A CN102526610A CN 102526610 A CN102526610 A CN 102526610A CN 2011104514072 A CN2011104514072 A CN 2011104514072A CN 201110451407 A CN201110451407 A CN 201110451407A CN 102526610 A CN102526610 A CN 102526610A
- Authority
- CN
- China
- Prior art keywords
- gram
- chinese medicine
- radix
- takayasu arteritis
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses traditional Chinese medicine for curing multiple takayasu arteritis. Raw materials comprise radix achyranthis bidentatae 12g, astragalus mongholicus 16g, carthamus tinctorius 12g, curcuma aromatica 18g, radix paeoniae rubra 15g, panax pseudoginseng 10g, prepared rehmannia root 15g, pollen typhae 15g, radix ophiopogonis 18g and rhizoma polygonati 20g. The raw materials are mixed evenly and smashed into fine powder with 150 meshes, the fine powder is filled into bags respectively, and each bag contains 6g of medicine powder. One bag of traditional Chinese medicine is taken after a meal every day and is taken at twice after mixing with water, and the traditional Chinese medicine has remarkable effect on treatment of the multiple takayasu arteritis.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to a kind of Chinese medicine of treating multiple takayasu arteritis, is the Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
The background technology multiple takayasu arteritis is a species specificity autoimmune disease, is aorta and main ramose multiple, nonsuppurative inflammation disease thereof.Primary disease is sent out well in the teenager women; Its clinical characters is to cause the narrow or inaccessible symptom that causes owing to aorta and branch's inflammation thereof; Western medical treatment should disease be main with hormone, immunosuppressant at present; But the side effect of hormone is huge, can bring other severe complications (as occurring disease such as hypoadrenocorticism behind the hormone of stopping using) to human body.Motherland's medical science thinks that primary disease is many because of the natural endowment deficiency; Lose the day after tomorrow in taking good care of; The exopathogen invasion of taking advantage of a weak point in opponent's defence, numbness hinders in arteries and veins, so that due to the imbalance of YIN and YANG, deficiency of both QI and blood; The promoting flow of QI and blood of Chinese medicine, regulate negative and positive treatment should disease aspect tool use great potential, so invent that a kind of Chinese medicine of treating multiple takayasu arteritis treats should disease.
It is the medicine of the treatment multiple takayasu arteritis of the rule of treatment with promoting flow of QI and blood, adjusting negative and positive that summary of the invention the purpose of this invention is to provide a kind of, to overcome the deficiency of prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's medical tradition medical science multiple takayasu arteritis; With reference to modern pharmacological research; Therefrom filter out the natural Chinese medicinal herb of promoting flow of QI and blood, adjusting negative and positive,, it is played a role by the theory of Chinese medical science prescription.
Medicine of the present invention is processed by following component:
The Radix Achyranthis Bidentatae 12 gram Radixs Astragali 16 gram Flos Carthamis 12 gram Radix Curcumaes 18 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Radix Rehmanniae Preparata 15 gram Pollen Typhaes 15 gram 18 gram Rhizoma Polygonatis Radix Ophiopogonis 20 grams
Above-mentioned each component mix homogeneously is ground into 150 order fine powders, is distributed into bag, every packed medicated powder 6 grams.One after each meal, is used mixing in water for oral taking at twice at one bag of every day.
Medicine of the present invention is a Chinese medicine preparation, and is theoretical according to traditional Chinese medical science prescription, select medicine rationally, promoting flow of QI and blood, adjusting negative and positive, treating both the principal and secondary aspects of a disease.Medicine of the present invention, warp is the clinical observation patient for many years, and evident in efficacy, the multiple takayasu arteritis patient that a variety of causes is caused has remarkable result.
Clinical drug of the present invention is taken the result and is shown, following advantage is arranged:
It is raw material that the present invention selects natural plant for use, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment multiple takayasu arteritis of the medicine of respectively distinguishing the flavor of, and no chemicals is harmless to human non-toxic, has no side effect, and is safe and reliable; The present invention is a powder, and effective ingredient scatters and disappears few, and curative effect is high, and is cheap, taking convenience, no any discomfort disease; Medicine of the present invention is obvious to the multiple takayasu arteritis curative effect; Clinical drug of the present invention is observed, the medicine of instead other treatment multiple takayasu arteritis.
The clinical observation in year surplus the Chinese medicine for oral administration powder of the present invention, warp ten, one month is a course of treatment, and nearly 1000 examples of treatment patient, state of an illness symptom disappear to effective, and total effective rate is 95%.
Model case: in so-and-so, woman, 14 years old, first visit on July 8 in 2004.Dizzy headache appears in patient's no obvious inducement before 2 months.Blurred vision, is sent out coolly, unable etc. at two upper limb numbness, through certain examination in hospital, is diagnosed as multiple takayasu arteritis.Take a turn for the better to some extent through the hormone therapy above-mentioned symptom; But still must every day oral prednisone keep for 50 milligrams; Make referrals to my institute's treatment through other people and take Chinese medicine of the present invention after one month (hormone of stopping using gradually during obeying Chinese medicine of the present invention); Above-mentioned symptom disappears, the bimester of taking Chinese medicine of the present invention again after, conditions of patients takes a turn for the better fully.
The specific embodiment:
Choose raw material by following proportioning:
The Radix Achyranthis Bidentatae 12 gram Radixs Astragali 16 gram Flos Carthamis 12 gram Radix Curcumaes 18 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Radix Rehmanniae Preparata 15 gram Pollen Typhaes 15 gram 18 gram Rhizoma Polygonatis Radix Ophiopogonis 20 grams; Above-mentioned each component mix homogeneously is ground into 150 order fine powders, is distributed into bag, every packed medicated powder 6 grams.
Claims (1)
1. a Chinese medicine of treating multiple takayasu arteritis is characterized in that it is the powder of being processed by the following weight proportion raw material: the Radix Achyranthis Bidentatae 12 gram Radixs Astragali 16 gram Flos Carthamis 12 gram Radix Curcumaes 18 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Radix Rehmanniae Preparata 15 gram Pollen Typhaes 15 gram 18 gram Rhizoma Polygonatis Radix Ophiopogonis 20 grams; Above-mentioned each component mix homogeneously is ground into 150 order fine powders, promptly gets medicine of the present invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104514072A CN102526610A (en) | 2011-12-20 | 2011-12-20 | Traditional Chinese medicine for curing multiple takayasu arteritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104514072A CN102526610A (en) | 2011-12-20 | 2011-12-20 | Traditional Chinese medicine for curing multiple takayasu arteritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102526610A true CN102526610A (en) | 2012-07-04 |
Family
ID=46335430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104514072A Pending CN102526610A (en) | 2011-12-20 | 2011-12-20 | Traditional Chinese medicine for curing multiple takayasu arteritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526610A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105327093A (en) * | 2015-12-10 | 2016-02-17 | 雷小明 | Chinese herbal preparation for treating polyarteritis and preparing method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040022869A1 (en) * | 2001-11-30 | 2004-02-05 | Chen Lan Bo | Methods and compositions for modulating the immune system and uses thereof |
| WO2004094613A2 (en) * | 2003-04-22 | 2004-11-04 | Ibc Pharmaceuticals | Polyvalent protein complex |
| US20050261170A1 (en) * | 2004-01-22 | 2005-11-24 | Immunomedics, Inc. | Folate conjugates and complexes |
| CN101099847A (en) * | 2006-07-07 | 2008-01-09 | 黄振华 | Medicine for treating cardiac and cerebral vascular disease |
| CN101991816A (en) * | 2010-11-12 | 2011-03-30 | 李奕星 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
-
2011
- 2011-12-20 CN CN2011104514072A patent/CN102526610A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040022869A1 (en) * | 2001-11-30 | 2004-02-05 | Chen Lan Bo | Methods and compositions for modulating the immune system and uses thereof |
| WO2004094613A2 (en) * | 2003-04-22 | 2004-11-04 | Ibc Pharmaceuticals | Polyvalent protein complex |
| US20050261170A1 (en) * | 2004-01-22 | 2005-11-24 | Immunomedics, Inc. | Folate conjugates and complexes |
| CN101099847A (en) * | 2006-07-07 | 2008-01-09 | 黄振华 | Medicine for treating cardiac and cerebral vascular disease |
| CN101991816A (en) * | 2010-11-12 | 2011-03-30 | 李奕星 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
Non-Patent Citations (1)
| Title |
|---|
| 董建勇等: "中医药治疗脑动脉硬化症研究进展", 《甘肃中医学院学报》, vol. 18, no. 1, 31 March 2001 (2001-03-31) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105327093A (en) * | 2015-12-10 | 2016-02-17 | 雷小明 | Chinese herbal preparation for treating polyarteritis and preparing method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101816776B (en) | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof | |
| CN101926870B (en) | Astragalus dandelion soup for treating chronic atrophic gastritis | |
| CN103341004A (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN101837112B (en) | Chinese medicinal composition for curing irregular menstrual period and preparation method thereof | |
| CN101829308A (en) | Traditional Chinese medicine combination for treating amenorrhea and preparation method thereof | |
| CN103272194A (en) | Drug for treating gynecological menstruation | |
| CN104940485A (en) | Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof | |
| CN102363022A (en) | Chinese medicine for treating postpartum anemic fainting | |
| CN101966289A (en) | Chinese medicinal composition for treating frigidity and preparation method thereof | |
| CN101829315B (en) | Traditional Chinese medicine composition for treating headache during menstruation and preparation method thereof | |
| CN101491612B (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
| CN102526613B (en) | Medicament for treating allergic cutaneous vasculitis | |
| CN102526610A (en) | Traditional Chinese medicine for curing multiple takayasu arteritis | |
| CN101850101B (en) | Chinese medicinal composition for treating metrostaxis and preparation method thereof | |
| CN106581299B (en) | Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof | |
| CN102614373A (en) | Patch for treating aortic arch syndrome | |
| CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy | |
| CN102512589B (en) | Medicine for treating early sudden deafness | |
| CN102552569B (en) | Medicine for treating renal artery type arteritis | |
| CN102512546B (en) | Traditional Chinese medicine used for esophageal cancer patients refusing surgery | |
| CN102908598B (en) | Medicine for treating children fungal pneumonia | |
| CN102973803A (en) | Drug for treating hematopathy primary thrombocytopenic purpura | |
| CN102406875A (en) | Drug for treating endometriosis interna | |
| CN101843756B (en) | Chinese medicament for treating chronic nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120704 |